You can stimulate your own GLP-1 naturally through food and exercise
A quiet but consequential shift is underway in how medicine thinks about weight and metabolic health. British physicians, drawing on years of clinical practice, are demonstrating that the body possesses its own pharmaceutical logic — that deliberate choices around food and timing can activate the same hormonal pathways targeted by blockbuster drugs like Ozempic, without the injections, the costs, or the documented risks. This is not a rejection of modern medicine so much as a reminder that the body, given the right conditions, has always known how to heal.
- GLP-1 drugs have captured global attention with dramatic weight loss results, but a BMJ investigation linking them to 82 deaths and widespread unsupervised use has cast a long shadow over their promise.
- British physician Dr. David Unwin has guided 151 patients into diabetes remission through diet alone, saving the NHS 370,000 pounds in drug costs — a quiet disruption to the pharmaceutical narrative.
- Three dietary strategies — low-carb, ketogenic, and intermittent fasting — are showing clinical results that rival medication, with patients losing 10 kilograms or more annually and some eliminating prescriptions entirely.
- Real patients like Kirsten Linaker, who lost 32 kilograms after GLP-1 injections failed her, and Donna Brewer, who shed over 117 kilograms through a combined lifestyle plan, are becoming the evidence base.
- Doctors warn that appetite suppression alone is insufficient — without resistance training and adequate protein, patients risk muscle loss and rebound weight gain, making integrated approaches essential for lasting change.
British doctors are quietly assembling a case that could reshape how millions think about weight loss. They are not arguing against GLP-1 medications like Ozempic and Wegovy — drugs that demonstrably help patients lose 15 to 20 percent of their body weight and reduce heart attack risk. They are arguing that the body can achieve much of the same result on its own, through food choices and timing, without injections or the risks that accompany them. A BMJ investigation has documented 82 deaths associated with these drugs, and many people obtain them online without medical supervision, assuming safety that hasn't been established.
Dr. David Unwin, who has treated obesity and diabetes at an NHS clinic in Southport for over a decade, has guided 151 patients into diabetes remission without medication — 27 percent of his diabetic population. He's saved the health system 370,000 pounds in drug costs. His approach centers on a simple premise: food and exercise can naturally stimulate the same GLP-1 hormone that pharmaceutical companies have spent billions learning to mimic.
Three dietary paths emerge from the research. Low-carbohydrate eating shifts the body toward burning fat, with Unwin's patients losing an average of 10 kilograms in their first year. Patient Kirsten Linaker, 48, lost nearly 32 kilograms this way after GLP-1 injections disappointed her, stopped her diabetes medication, and found her cravings disappeared. The ketogenic diet, more restrictive at 20 to 50 grams of carbohydrates daily, produces half a kilo to one kilo of weekly loss according to Dr. Eric Westman at Duke University; his patient Sharon Grey reversed type 2 diabetes and fatty liver disease in 13 months. Intermittent fasting — eating within an eight-hour window — produces 5 to 9 percent weight loss over several months, and just three days of it improved blood sugar control in type 2 diabetics in research by Dr. Kelly Bowden Davies. Donna Brewer lost more than 117 kilograms combining fasting, low-carb eating, exercise, and habit change. "It's not like a diet," she said. "It's more a shift in mindset."
The physicians consulted agree these approaches work best together, and warn that suppressing appetite without improving diet quality risks protein deficiency, muscle loss, and eventual weight regain. The GLP-1 boom has at least focused public attention on metabolic health. The harder task now is offering something more durable than a prescription — a way of living that patients can sustain long after the medication, or the motivation, runs out.
British doctors are quietly building a case that might reshape how millions approach weight loss. They're not arguing against the medications that have dominated headlines—the GLP-1 drugs like Ozempic and Wegovy that promise to melt away pounds. Instead, they're demonstrating something simpler: the body can do much of this work on its own, through food choices and timing, without injections or the risks that come with them.
The appeal of GLP-1 medications is straightforward. These drugs mimic an intestinal hormone that tells your brain you're full, slows digestion, and steadies blood sugar. Clinical trials show patients lose 15 to 20 percent of their body weight. They improve cholesterol, blood pressure, and reduce heart attack risk by 14 percent. The drugs work. But they also carry a shadow: a BMJ investigation documented 82 deaths associated with them, and many people obtain them online without medical oversight, assuming they're risk-free.
Dr. David Unwin, a British physician who has spent more than a decade treating obesity and diabetes at an NHS clinic in Southport, argues there's an alternative that's been overlooked. "You can stimulate your own GLP-1 naturally through food and exercise," he says. His evidence comes from his own patients. Over the years, he's guided 151 people into diabetes remission without medication—27 percent of his diabetic population. He's saved the health system 370,000 pounds in diabetes drugs. Among his type 2 diabetic patients, 51 percent achieve remission, 47 percent see their disease improve, and more than 90 percent of those with prediabetes return to normal blood sugar levels.
Three dietary approaches emerge from the research. The first is low-carbohydrate eating. By cutting refined sugars and starchy foods, the body shifts to burning fat for energy. Unwin's patients lose an average of 10 kilograms in their first year. Kirsten Linaker, 48, tried this after GLP-1 injections disappointed her. She lost nearly 32 kilograms, stopped her diabetes medication, and found her cravings vanished. The second is the ketogenic diet, more restrictive at 20 to 50 grams of carbohydrates daily, pushing the body into ketosis. Dr. Eric Westman at Duke University reports his patients lose between half a kilo and one kilo weekly, and he can safely discontinue medications for diabetes, high blood pressure, heartburn, and arthritis. Sharon Grey, 56, reversed her type 2 diabetes and fatty liver disease in 13 months on keto; her blood pressure normalized and her pain eased. The third is intermittent fasting—eating within an eight-hour window and fasting for sixteen hours, for example. Research shows this produces 5 to 9 percent weight loss over three to twelve months. Dr. Kelly Bowden Davies at Manchester Metropolitan University found that just three days of intermittent fasting improved blood sugar control in type 2 diabetics. Donna Brewer, 48, lost more than 117 kilograms following a 28-day plan combining intermittent fasting, low-carb eating, exercise, and habit change. "It's not like a diet," she said. "It's more a shift in mindset."
The doctors consulted by The Telegraph agree on one point: these approaches work best when combined. Dr. Campbell Murdoch, who created the 28-day Metabolic Health Plan, warns that reducing appetite without improving diet quality can lead to protein deficiency, muscle loss, and weight regain once treatment stops. "You need to combine these approaches with resistance training and proper nutrition, especially protein," he says. The GLP-1 boom at least put metabolic health in focus. Now the challenge is offering something more durable than a prescription—a way of living that patients can sustain, that doesn't depend on a drug supply or a doctor's approval, and that builds health rather than managing its absence.
Notable Quotes
You can stimulate your own GLP-1 naturally through food and exercise— Dr. David Unwin, British physician
The GLP-1 boom at least put metabolic health in focus. Now we need to offer integrated solutions that include healthy lifestyle, not just medications— Dr. Campbell Murdoch, creator of the 28-day Metabolic Health Plan
The Hearth Conversation Another angle on the story
Why are British doctors suddenly talking about this? GLP-1 drugs are working. People are losing weight.
They are working, but there's a catch. The drugs work as long as you take them. Stop, and the weight often comes back. Plus there are side effects, and 82 documented deaths. These doctors are saying: what if we taught people to do this themselves?
But isn't that just old advice dressed up new? Eat less, move more?
Not quite. It's about understanding *why* the body stops being hungry. GLP-1 is a hormone your gut makes naturally when you eat certain ways. Low-carb, keto, intermittent fasting—they all trigger it. The drug is just copying what your body can already do.
So why hasn't this worked before? People have tried diets for decades.
Because most diets are temporary. You white-knuckle through them, then stop. These doctors are saying the shift has to be deeper—a change in how you think about food, not just what you eat. And they're showing it works: people getting off diabetes medication, losing 30, 100 kilograms.
What's the catch with these diets? There has to be one.
Keto can cause fatigue and nausea at first. All of them require discipline. And they need medical supervision if you're already on medications. But the catch with GLP-1 is bigger: you're dependent on it, and you're paying for it, and nobody really knows the long-term effects.
So these doctors think the answer is just... eating differently?
Not just eating. Eating differently, moving regularly, and understanding that your body has its own chemistry. The drug companies didn't invent appetite control. They just bottled it.